Shares of Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five ratings firms that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, one has issued a buy rating and two have issued a strong buy rating on the company.
Several brokerages have weighed in on ACB. Wall Street Zen downgraded Aurora Cannabis from a "hold" rating to a "sell" rating in a research report on Friday, July 18th. Zacks Research upgraded Aurora Cannabis to a "strong sell" rating in a research report on Friday, August 8th. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Aurora Cannabis in a research report on Saturday, September 27th.
View Our Latest Analysis on Aurora Cannabis
Institutional Trading of Aurora Cannabis
Several large investors have recently modified their holdings of the business. State of Wyoming boosted its position in Aurora Cannabis by 10.5% during the 2nd quarter. State of Wyoming now owns 23,722 shares of the company's stock valued at $101,000 after acquiring an additional 2,246 shares in the last quarter. Headlands Technologies LLC bought a new stake in Aurora Cannabis during the 2nd quarter valued at approximately $66,000. Tidal Investments LLC lifted its holdings in shares of Aurora Cannabis by 6.0% during the second quarter. Tidal Investments LLC now owns 1,509,483 shares of the company's stock valued at $6,400,000 after purchasing an additional 86,045 shares during the last quarter. Engineers Gate Manager LP purchased a new position in shares of Aurora Cannabis during the second quarter valued at approximately $68,000. Finally, AdvisorShares Investments LLC purchased a new position in shares of Aurora Cannabis during the second quarter valued at approximately $214,000. 47.63% of the stock is owned by institutional investors.
Aurora Cannabis Stock Down 0.5%
ACB stock traded down $0.03 during trading on Friday, reaching $5.65. 1,559,031 shares of the stock were exchanged, compared to its average volume of 1,859,396. The firm's 50 day moving average is $5.02 and its 200 day moving average is $4.84. Aurora Cannabis has a twelve month low of $3.42 and a twelve month high of $6.91. The company has a current ratio of 2.97, a quick ratio of 1.51 and a debt-to-equity ratio of 0.06. The firm has a market cap of $317.64 million, a P/E ratio of -29.74 and a beta of 1.75.
Aurora Cannabis (NASDAQ:ACB - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by ($0.37). Aurora Cannabis had a negative return on equity of 1.49% and a negative net margin of 5.66%.The firm had revenue of $71.98 million for the quarter, compared to analyst estimates of $96.83 million. As a group, research analysts forecast that Aurora Cannabis will post 0.46 EPS for the current year.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.